ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency ecology disease medicine genetics genomics microbiology

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
The cholera genome: an advance for science or for medicine?
Robert Walgate | Aug 7, 2000 | 6 min read
genome sequence will help in developing protection against the disease. Robert Walgate discovers that it might - but perhaps not in the most obvious ways.
An illustration of green bacteria floating above neutral-colored intestinal villi
The Inside Guide: The Gut Microbiome’s Role in Host Evolution
Catherine Offord | Jul 1, 2021 | 10+ min read
Bacteria that live in the digestive tracts of animals may influence the adaptive trajectories of their hosts.
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Notebook
Paul Smaglik | Nov 21, 1999 | 6 min read
Contents Pivotal pump Leptin limbo Clue to obesity Biotech Web site Helping hand Mapping malaria UCSD - Salk Program in Molecular Medicine HEART FAILURE RESCUE: A cross section of a mouse genetically engineered to develop heart failure (left) shows enlarged heart chambers and thin walls that are typical of the condition. A cross section from the same strain of mouse, but with the phospholamban gene (PLB) also missing, appears normal. PIVOTAL PUMP A biochemical calcium pump and the gene that con
Collaborative Efforts Under Way To Combat Malaria
Alison Mack | May 11, 1997 | 8 min read
Sidebars Malaria: A Statistical Index Funding Agencies For Malaria Research Researchers in the field lament what they call gross underfunding, but say a joint approach will help ensure that avaliable monies are well spent. After several years of declining interest in malaria research and decreasing support for such studies, the field is gaining much-needed momentum. Spurred in part by an international conference held in Dakar, Senegal, in January, funding agencies and scientists around the gl
Renewing the Fight Against Bacteria
Jennifer Fisher Wilson | Mar 3, 2002 | 6 min read
In the 1940s, the mass production of penicillin led to a sensational reduction in illness and death from bacterial disease. A resulting golden era of bacterial research emerged with new classes of antibiotics, and by 1969, US Surgeon General William H. Stewart told Congress: "The time has come to close the book on infectious disease." As a result, fewer new students specialized in bacterial physiology, and federal funders shifted their focus to more immediately pressing diseases, as did many pha
Researchers in Administration
Karen Young Kreeger | Nov 12, 2000 | 6 min read
Much of the administration of the scientific endeavor can be neatly placed into two groups: those who work at acquiring the money, and those who work at bestowing the money. Mostly at universities and colleges, the acquirers direct offices of sponsored research, large research departments, or can be vice presidents of research or graduate schools. The bestowers are primarily program officers at such government agencies as the National Institutes of Health and the National Science Foundation and

Run a Search

ADVERTISEMENT